Arbutus Biopharma (ABUS) Accumulated Depreciation & Amortization: 2010-2025
Historic Accumulated Depreciation & Amortization for Arbutus Biopharma (ABUS) over the last 13 years, with Sep 2025 value amounting to $11,000.
- Arbutus Biopharma's Accumulated Depreciation & Amortization fell 96.73% to $11,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 3.10%. This contributed to the annual value of $13.0 million for FY2024, which is 9.21% up from last year.
- Per Arbutus Biopharma's latest filing, its Accumulated Depreciation & Amortization stood at $11,000 for Q3 2025, which was down 0.00% from $11,000 recorded in Q2 2025.
- Over the past 5 years, Arbutus Biopharma's Accumulated Depreciation & Amortization peaked at $13.0 million during Q4 2024, and registered a low of $11,000 during Q2 2025.
- For the 3-year period, Arbutus Biopharma's Accumulated Depreciation & Amortization averaged around $2.5 million, with its median value being $342,000 (2023).
- In the last 5 years, Arbutus Biopharma's Accumulated Depreciation & Amortization climbed by 23.00% in 2021 and then crashed by 96.91% in 2025.
- Over the past 5 years, Arbutus Biopharma's Accumulated Depreciation & Amortization (Quarterly) stood at $9.4 million in 2021, then grew by 15.22% to $10.8 million in 2022, then grew by 10.17% to $11.9 million in 2023, then rose by 9.21% to $13.0 million in 2024, then plummeted by 96.73% to $11,000 in 2025.
- Its Accumulated Depreciation & Amortization stands at $11,000 for Q3 2025, versus $11,000 for Q2 2025 and $330,000 for Q1 2025.